SEARCH

SEARCH BY CITATION

References

  • 1
    Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378383.
  • 2
    Cecka JM. The UNOS renal transplant registry. Clin Transpl 2002: 120.
  • 3
    Leventhal J, Kaufman D, Gallon L et al. Four years single center experience with prednisone free immunosuppression in 434 kidney transplant recipients. Am J Transplant 2003; 3 (suppl 5): S439.
  • 4
    Kaufman D, Leventhal J, Gallon L et al. Long-term results of kidney transplantation in the prednisone-free era. Am J Transplant 2003; 3 (suppl 5): S198.
  • 5
    Davies DR, Bittmann I, Pardo J. Histopathology of calcineurin inhibitor-induced nephrotoxicity. Transplantation 2000; 69: SS11SS13.
  • 6
    Bennett WM. Insights into chronic cyclosporine nephrotoxicity. Int J Clin Pharmacol Ther 1996; 34: 515519.
  • 7
    Bertani T, Ferrazzi P, Schieppati A et al. Nature and extent of glomerular injury induced by cyclosporine in heart transplant patients. Kidney Int 1991; 40: 243250.
  • 8
    Solez K, Vincenti F, Filo RS. Histopathologic findings from 2-year protocol biopsies from a U.S. multicenter kidney transplant trial comparing tacrolimus versus cyclosporine: A report of the FK506 kidney transplant study group. Transplantation 1998; 66: 17361740.
  • 9
    Remuzzi G, Perico N. Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int Suppl 1995; 52: S70S74.
  • 10
    Pascual M, Swinford RD, Ingelfinger JR, Williams WW, Cosimi AB, Tolkoff-Rubin N. Chronic rejection and chronic cyclosporin toxicity in renal allografts. Immunol Today 1998; 19: 514519.
  • 11
    Myers B, Newton L. Cyclosporine-induced chronic nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 1991; 2: 545552.
  • 12
    Nankivell BJ, Borrows RJ, Fung CL, O'Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 23262333.
  • 13
    Kaplan B, Schold JD, Meier-Kriesche HU. Long-term graft survival with neoral and tacrolimus: A paired kidney analysis. J Am Soc Nephrol 2003; 14: 29802984.
  • 14
    Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931940.
  • 15
    Paramesh AS, Roayaie S, Doan Y et al. Post-liver transplant acute renal failure: Factors predicting development of end-stage renal disease. Clin Transplant 2004; 18: 9499.
  • 16
    Meier-Kriesche HU, Steffen BJ, Chu AH et al. Sirolimus with neoral versus mycophenolate mofetil with neoral is associated with decreased renal allograft survival. Am J Transplant 2004; 4: 20582066.
  • 17
    Halloran P, Ahsan N, Johnson C et al. Three-years follow up of randomized kidney transplant study comparing tacrolimus (Tac) + Azathioprine (Aza) vs. cyclosporine modified (CsA) + mycophenolate mofetil (MMF) vs. Tac + MMF. Am J Transplant 2001; 1 (Suppl 1): S405.
  • 18
    Ahsan N, Johnson C, Gonwa T et al. Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years. Transplantation 2001; 72: 245250.
  • 19
    Gaspari F, Ferrari S, Stucchi N et al. Performance of different prediction equations for estimating renal function in kidney transplantation. Am J Transplant 2004; 4: 18261835.
  • 20
    McTaggart RA, Gottlieb D, Brooks J et al. Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003; 3: 416423.
  • 21
    Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S. Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003; 76: 15941599.
  • 22
    Cattaneo D, Merlini S, Pellegrino M et al. Therapeutic drug monitoring of sirolimus: Effect of concomitant immunosuppressive therapy and optimization of drug dosing. Am J Transplant 2004; 4: 13451351.
  • 23
    Napoli KL, Taylor PJ. From beach to bedside: History of the development of sirolimus. Ther Drug Monit 2001; 23: 559586.
  • 24
    Undre NA. Pharmacokinetics of tacrolimus-based combination therapies. Nephrol Dial Transplant 2003; 18: i12i15.
  • 25
    Undre NA, Van Hooff J, Christiaans M et al. Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. Transplant Proc 1998; 30: 12991302.
  • 26
    Andoh TF, Burdmann EA, Fransechini N, Houghton DC, Bennett WM. Comparison of acute rapamycin nephrotoxicity with cyclosporine and FK506. Kidney Int 1996; 50: 11101117.
  • 27
    Andoh TF, Lindsley J, Franceschini N, Bennett WM. Synergistic effects of cyclosporine and rapamycin in a chronic nephrotoxicity model. Transplantation 1996; 62: 311316.
  • 28
    Shihab FS, Bennett WM, Yi H, Choi SO, Andoh TF. Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity. Kidney Int 2004; 65: 12621271.
  • 29
    Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994; 331: 12861292.
  • 30
    Flechner SM, Kurian SM, Solez K et al. De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function at two years. Am J Transplant 2004; 4: 17761785.
  • 31
    Mele TS, Halloran PF. The use of mycophenolate mofetil in transplant recipients. Immunopharmacology 2000; 47: 215245.
  • 32
    Meier-Kriesche H, Schold J, Srinivas T, Howard R, Fujita S, Kaplan B. Sirolimus in combination with tacrolimus is associated with worse renal allograft survival compared to mycophenolate mofetil combined with tacrolimus. Am J Transplant 2005; 5: 22732280.
  • 33
    Kaplan B, School J, Srinivas T et al. Effect of sirolimus withdrawal in patients with deteriorating renal function. Am J Transplant 2004; 4: 2332.
  • 34
    Mendez R, Gonwa T, Yang HC, Weinstein S, Jensik S, Steinberg S. A prospective, randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 1 year. Transplantation 2005; 80: 303309.